ConductScience.org, home

Paper21397026

Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I.

Wolf DA and 7 others. Neurobiol Dis, 2011. Cited by 65 papers, by iCite.

Cite this record

ConductScience Library. Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I. Papers, record 21397026. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21397026

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I.
PubMed
Journal
Neurobiol Dis
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
65
iCite
Relative citation ratio, by iCite
1.99
iCite
Revised in PubMed
2025-05-29
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wolf DADaniel A
2Lenander AWAndrew W
3Nan ZZhenhong
4Belur LRLalitha R
5Whitley CBChester B
6Gupta PPankaj
7Low WCWalter C
8McIvor RSR Scott

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Genetic TherapyMajor topic
IduronidaseMajor topic
Mucopolysaccharidosis IMajor topic
Transduction, GeneticMajor topic
Adenoviridae
Animals
Animals, Newborn
Disease Models, Animal
Female
Humans
Infusions, Intraventricular
Male
Mice
Mice, Mutant Strains
Up-Regulation

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 HD032652NICHD NIH HHSUnited StatesP01HD032652PubMed and NIHNIH RePORTER
T32 DA022616NIDA NIH HHSUnited StatesT32DA022616PubMed and NIHNIH RePORTER
P01HD032652NICHD NIH HHSUnited StatesP01HD032652PubMed and NIHNIH RePORTER
T32 DA022616-01NIDA NIH HHSUnited StatesT32DA022616PubMed and NIHNIH RePORTER

Download CSV of grants

References76

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110051635Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10051635PubMed
217519893Correction of clinical manifestations of canine mucopolysaccharidosis I with neonatal retroviral vector gene therapy.Mol Ther2007https://conductscience.org/library/papers/17519893PubMed
38213840Identification of mutations in the alpha-L-iduronidase gene (IDUA) that cause Hurler and Scheie syndromes.Am J Hum Genet1993https://conductscience.org/library/papers/8213840PubMed
43041032A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication.J Virol1987https://conductscience.org/library/papers/3041032PubMed
515558784Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders.J Comp Neurol2004https://conductscience.org/library/papers/15558784PubMed
610480370The frequency of lysosomal storage diseases in The Netherlands.Hum Genet1999https://conductscience.org/library/papers/10480370PubMed
716221840Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors.J Neurosci2005https://conductscience.org/library/papers/16221840PubMed
88058211Cerebellar contributions to instrumental learning.Neurosci Biobehav Rev1994https://conductscience.org/library/papers/8058211PubMed
916414198Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.Neuroscience2006https://conductscience.org/library/papers/16414198PubMed
1021139569Safe, efficient, and reproducible gene therapy of the brain in the dog models of Sanfilippo and Hurler syndromes.Mol Ther2011https://conductscience.org/library/papers/21139569PubMed
118704199Humoral immune response limits gene therapy in canine MPS I.Blood1996https://conductscience.org/library/papers/8704199PubMed
129523395Neonatal immunology.Semin Perinatol1998https://conductscience.org/library/papers/9523395PubMed
1315229474Neonatal adaptive immunity comes of age.Nat Rev Immunol2004https://conductscience.org/library/papers/15229474PubMed
1419098898Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.Nat Biotechnol2009https://conductscience.org/library/papers/19098898PubMed
15438323Excretion-reuptake route of beta-hexosaminidase in normal and I-cell disease cultured fibroblasts.J Clin Invest1979https://conductscience.org/library/papers/438323PubMed
1617180118Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 rhesus macaque-derived adeno-associated virus vector.Mol Ther2007https://conductscience.org/library/papers/17180118PubMed
1711273777Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII.Mol Ther2001https://conductscience.org/library/papers/11273777PubMed
189672523Follow-up of nine patients with Hurler syndrome after bone marrow transplantation.J Pediatr1998https://conductscience.org/library/papers/9672523PubMed
199749724Comparing the effects of selective cingulate cortex lesions and cingulum bundle lesions on water maze performance by rats.Eur J Neurosci1998https://conductscience.org/library/papers/9749724PubMed
2018037941Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome.Bone Marrow Transplant2008https://conductscience.org/library/papers/18037941PubMed

See all 76 referencesDownload CSV of references

Cited by49

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.

PMIDTitleJournalYearIn PapersSource
39687731Intrathecal or intravenous AAV9-IDUA/RGX-111 at minimal effective dose prevents cardiac, skeletal and neurologic manifestations of murine MPS I.Mol Ther Methods Clin Dev2024https://conductscience.org/library/papers/39687731PubMed
38906479Adeno-associated virus vector delivery to the brain: Technology advancements and clinical applications.Adv Drug Deliv Rev2024https://conductscience.org/library/papers/38906479PubMed
38397051Efficacy of a Combination Therapy with Laronidase and Genistein in Treating Mucopolysaccharidosis Type I in a Mouse Model.Int J Mol Sci2024https://conductscience.org/library/papers/38397051PubMed
37543633Mapping brain networks in MPS I mice and their restoration following gene therapy.Sci Rep2023https://conductscience.org/library/papers/37543633PubMed
36704405Non-invasive intravenous administration of AAV9 transducing iduronate sulfatase leads to global metabolic correction and prevention of neurologic deficits in a mouse model of Hunter syndrome.Mol Genet Metab Rep2023https://conductscience.org/library/papers/36704405PubMed
36541357Neurologic Recovery in MPS I and MPS II Mice by AAV9-Mediated Gene Transfer to the CNS After the Development of Cognitive Dysfunction.Hum Gene Ther2023https://conductscience.org/library/papers/36541357PubMed
36457248Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier.Mol Ther2023https://conductscience.org/library/papers/36457248PubMed
36385771Routes of administration for adeno-associated viruses carrying gene therapies for brain diseases.Front Mol Neurosci2022https://conductscience.org/library/papers/36385771PubMed
36226412Phenotypic Correction of Murine Mucopolysaccharidosis Type II by Engraftment of Ex Vivo Lentiviral Vector-Transduced Hematopoietic Stem and Progenitor Cells.Hum Gene Ther2022https://conductscience.org/library/papers/36226412PubMed
36172050Delivering gene therapy for mucopolysaccharide diseases.Front Mol Biosci2022https://conductscience.org/library/papers/36172050PubMed
35573046Liver-directed gene therapy corrects neurologic disease in a murine model of mucopolysaccharidosis type I-Hurler.Mol Ther Methods Clin Dev2022https://conductscience.org/library/papers/35573046PubMed
35534672Improving Gene Therapy for Angelman Syndrome with Secreted Human UBE3A.Neurotherapeutics2022https://conductscience.org/library/papers/35534672PubMed
34502108Gene Therapy for Neuronopathic Mucopolysaccharidoses: State of the Art.Int J Mol Sci2021https://conductscience.org/library/papers/34502108PubMed
34189746Mucopolysaccharidoses type I gene therapy.J Inherit Metab Dis2021https://conductscience.org/library/papers/34189746PubMed
34040503Comparative Effectiveness of Intracerebroventricular, Intrathecal, and Intranasal Routes of AAV9 Vector Administration for Genetic Therapy of Neurologic Disease in Murine Mucopolysaccharidosis Type I.Front Mol Neurosci2021https://conductscience.org/library/papers/34040503PubMed
33924076Gene Therapy for Lysosomal Storage Disorders: Ongoing Studies and Clinical Development.Biomolecules2021https://conductscience.org/library/papers/33924076PubMed
33572941Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement.Biomolecules2021https://conductscience.org/library/papers/33572941PubMed
32461912Intravenous delivery for treatment of mucopolysaccharidosis type I: A comparison of AAV serotypes 9 and rh10.Mol Genet Metab Rep2020https://conductscience.org/library/papers/32461912PubMed
32201668A basic understanding of mucopolysaccharidosis: Incidence, clinical features, diagnosis, and management.Intractable Rare Dis Res2020https://conductscience.org/library/papers/32201668PubMed
30844402Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality.Neuron2019https://conductscience.org/library/papers/30844402PubMed

See all 49 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IDUA3425PubTator's text mininghttps://conductscience.org/library/genes/3425

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21397026

GET https://conductscience.org/api/papers/v1/21397026/references?page=2